INTRODUCTION
Our knowledge of the auxillary enzyme systems required during the f-oxidation of (poly)unsaturated enoyl-CoAs [2,4-dienoylCoA reductase (EC 1.3.1.34), 2-enoyl-CoA hydratase 2, A3,A2_ enoyl-CoA isomerase (EC 5.3.3.8 ) and A35,A24-dienoyl-CoA isomerase] has expanded during the past few years. New aspects include the observation that these enzymes often possess several isoforms distributed in different subcellular organelles, and occasionally within the same cell compartments .
2,4-Dienoyl-CoA reductase, which catalyses the reaction:
trans-2,cis/trans-4-dienoyl-CoA + NADPH + H+ --+ trans-3-enoyl-CoA + NADP+ in eukaryotes (Kunau and Dommes, 1978) , has been purified from several sources: rat liver (Kimura et al., 1984) , bovine liver (Dommes et al., 1982; Dommes and Kunau, 1984) , the yeasts Candida lipolytica (Mizugaki et al., 1985) and Candida tropicalis (Dommes et al., 1983) and the bacterium Escherichia coli (Mizugaki et al., 1982) . In contrast with eukaryotes, the end product of the bacterial reaction is trans-2-enoyl-CoA. Reductase activity in mammals has been shown to be associated with both mitochondria and peroxisomes (Dommes et al., 1981; Kimura et al., 1984; Hiltunen et al., 1986) , and two mitochondrial isoforms with native molecular masses of 60 and 120 kDa have also been observed in rat liver . The 120 kDa isoform comprises four identical subunits, each with a molecular mass of 36 kDa. This subunit has been recently cloned and sequenced (Hirose et al., 1990) . The necessity of 2,4-dienoyl-CoA 2,4-dienoyl-CoA reductase shows 82.7 % (81.7 %) similarity (identity) to the corresponding sequence from the rat. Northernblot analysis gave a single mRNA species of 1.2 kb in several human tissues, the amounts present in the tissues tested ranking as follows: heart liver -pancreas > kidney > skeletal muscle lung. Immunoblotting of human and rat liver samples with an antibody to the subunit of the rat 120 kDa isoform indicates that the mature human enzyme is larger than its counterpart in the rat. The comparison of amino acid sequences for rat and human enzymes proposes that the difference in the size is 10 amino acid residues. The results show that the rat and human reductases are similar in many characteristics and that the reductase is expressed in human tissues capable offl-oxidation of fatty acids.
reductase activity for ,-oxidation of (poly)unsaturated fatty acids has been suggested by several observations: (a) The uncoupling of isolated liver mitochondria lowers the intramitochondrial NADPH/NADP+ ratio and results in an accumulation of 2,4-dienoyl-CoA intermediates if polyunsaturated fatty acids are acting as the substrates for mitochondrial ,-oxidation (Hiltunen et al., 1983) . (b) Examination of solubilized peroxisome incubations has shown that the fl-oxidation of docosahexaenoic acid was markedly stimulated by added NADPH (Hiltunen et al., 1986) . (c) An E. coli mutant deficient in reductase activity was unable to utilize or grow on petroselinic acid (cis-CM8l(6)) (You et al., 1989) . (d) Furthermore, one patient has been identified with an inborn 2,4-dienoyl-CoA reductase dysfunction. Urinary excretion of 2-trans,4-cis-decadienoylcarnitine, derived from incomplete oxidation of linoleic acid (cis,cis-C18:2(912)), was observed, and in spite of dietary therapy, the patient died at the age of a few months (Roe et al., 1990) . In view of the arguments listed above and the important role which nutritional polyunsaturated fatty acids play in human wellbeing, we were prompted to undertake a project aimed at characterizing human 2,4-dienoyl-CoA reductases. We report in this paper on cDNA cloning of the mitochondrial 120 kDa isoform of human 2,4-dienoyl-CoA reductase. gel electrophoresis showed the amplified PCR fragments to be of the same size. The inserts were partially sequenced using the PCR-oligos as primers (Casanova et al., 1990 ).
MATERIALS AND METHODS
Ampliication of the N-terminus of 2,4-dienoyl-CoA reductase cDNA
Because the isolated hRed clones did not contain the 5'-terminal sequence of the reductase (see the Results section), a method with the anchor primer PCR was employed using the 5'-AmpliFINDER RACE Kit. mRNA isolated from human fibrosarcoma cells (2 ug) was taken as a template and first-strand cDNA synthesis was carried out with oligo F ( final extension time of 7 min. The amplified PCR fragment was subcloned to pUC18 with a SureClone Ligation Kit and both strands of the subcloned fragment were sequenced.
RT-PCR for the coding region of human mitochondrial 2,4-dienoyl-CoA reductase cDNA
The RT-PCR (Sambrook et al., 1989) was carried out to obtain the full-length cDNA for the coding region of the human reductase using oligo I as the primer for the RT reaction and mRNA (1 ,ug) from fibrosarcoma cells as the template. The PCR reaction was run using oligo H as the sense primer and oligo I as the antisense primer for 25 cycles under the following conditions: 1 min at 94 "C, 1 min at 56°C and 2 min at 72 'C. Thereafter the extensions were completed by incubating the reaction mixture for 10 min at 72 'C. The resulting PCR fragment (hRedT) was purified, subcloned to pUC18 and sequenced.
Southern hybridization
Total DNA was extracted from the blood of healthy men by the SDS-proteinase K method (Sambrook et al., 1989) and 15 jug of the isolated DNA was digested with EcoRI and Hindlll. The digested DNA was then subjected to Southern blotting by standard methods (Sambrook et al., 1989) . The blotted nitrocellulose filter was prehybridized for 4 h at 42 "C with 25 mM KH2PO4, 37.5 mM NaCl, 3.75 mM sodium citrate, 5 x Denhardt's solution, 50 ,ug/ml salmon sperm DNA and 50 % (v/v) formamide. The hybridization was performed overnight in the above solution supplemented with 32P-labelled hRedT probe and 10 % (w/v) dextran sulphate at 42 "C. The filter was washed twice with 0.15 M NaCl, 0.015 M sodium citrate, 0.1% (w/v) SDS at 42 "C for 15 min, and once at room temperature and once at 42 "C with 37.5 mM NaCl, 3.75 mM sodium citrate, 0.1 % SDS for 15 min before autoradiographing at -70 "C for 48 h using Kodak XAR film with an intensifying screen. Nucleotides are numbered in the 5' to 3' direction, beginning with the first nucleotide encoding the initiation methionine, which is termed + 1. The first nucleotide of the stop codon is in position +1006. The amino acid residues are numbered taking the initiation methionine as + 1. The polyadenylation signal is underlined. The proposed cleavage site of the mitochondrial targeting signal is indicated by an arrow.
Northern hybridization
A nylon membrane on which 2 ,ug aliquots of poly(A+) RNA from various human tissues had been blotted [Multiple Tissue Northern (MTN) Blot] was prehybridized at 42°C for 4 h and hybridized with 32P-labelled hRedT at 42°C for 20 h following the protocol provided by the supplier. The hybridized fragments were detected by exposing X-ray film at -70°C for 17 h. The amount of mRNA on the nylon membrane was standardized with a human ,-actin cDNA probe (supplied in the Kit).
Immunoblotting
Samples containing 100 ,ug of protein from rat and human liver homogenates were subjected to SDS/PAGE (Laemmli, 1970) followed by electrophoretic transfer of the proteins onto a nitrocellulose filter. Anti-(rat 2,4-dienoyl-CoA reductase) IgG (Hakkola et 
RESULTS
Screening of 5 x 105 independent recombinants in the human liver AgtlI cDNA library using a cDNA fragment for rat reductase (rRed) as the probe (see the Materials and methods section) yielded three positive clones (hRedl, -2 and -3). The PCR experiments, analysis of the amplified fragments by agarose gel electrophoresis and partial sequencing of the inserts indicated that the clones were identical, and thus only hRed 1 was taken for further characterization. To isolate the insert, the Agtl 1 clone containing hRedl was subjected to EcoRI digestion, as it was this restriction site that was used in the construction of the library. This resulted in three fragments of approx. 600, 200 and 130 bp, originating from the insert. The fragments were subcloned to Bluescript plasmids and both strands sequenced. Partial sequencing of the PCR-amplified, undigested hRedl-3 inserts (above) allowed the order of the EcoRI fragments to be deduced.
hRedl contained a poly(A+) tail and a signal for polyadenylation (AATAAA) 18 bp upstream of it. Because comparison of the hRedl sequence with the published rat 120 kDa reductase (reductase-120) nucleotide sequence (Hirose et al., 1990) indicated that the 5' end was missing, mRNA was isolated from cultivated human fibrosarcoma cells, ssDNA was synthe- To confirm that the cDNA sequences obtained really covered the whole region coding for the reductase-120 nucleotide sequence, an RT-PCR was carried out using mRNA isolated from human fibrosarcoma cells as the template and taking the sense oligo H and antisense oligo I as the primers. The amplified cDNA fragment (hRedT) covered both hRed I and hRed4 clones (Figure 1 ).
The cloned cDNA was 1128 bp long and contained an open reading frame with 1005 coding nucleotides and TAA as a stop codon, 110 non-coding 3' flanking nucleotides and 10 noncoding nucleotides flanking to the 5' end from the initiation ATG (Figure 2) . Adenine was in the -3 position, which is in the line with the observation that there is a purine (usually A) in this position in 970 of all vertebrate mRNAs (Kozak, 1991 Figure 3 Comparisons of the amino acid sequences of human and rat 2,4-dienoyl-CoA reductase Identical amino acid residues are marked by a vertical line and amino acid residues which show similarities are marked by a point. There is a 82.7% similarity between the rat and human 2,4-dienoyl-CoA reductase amino acid sequences. The first amino acids of the mature proteins are shown in bold face, these being deduced from N-terminal peptide sequencing of the purified rat enzyme (Hirose et al., 1990 ) and based on a prediction (see the Discussion section) in the case of the human enzyme. deduced polypeptide included 335 amino acid residues, with a predicted molecular mass of 36066 Da. The human reductase-120 nucleotide sequence thus has exactly the same number of amino acid residues as its rat counterpart (Hirose et al., 1990) .
Comparison of the human and rat 2,4-dienoyl-CoA reductases showed 82.7 % similarity in amino acid sequences (Figure 3 ) and 81.7 % identity in the coding nucleotides. In immunoblotting the antibody against the purified rat liver enzyme (Hakkola et al., 1989) recognized only one band in human liver homogenate (Figure 4) . However, the signal detected in human liver was slightly larger than in rat liver. For Northern blotting, 2 ,ug aliquots of mRNA isolated from various human tissues (heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas) were hybridized with hRedT as explained in the Materials and methods section. After 17 h of exposure, the signals for the brain and placenta tissues ( Figure  5a , lanes 2 and 3) were not detectable, while all the observed signals were 1.2 kb, which is close to the size of the isolated cDNA (1 128 bp). After normalizing the reductase signal intensity by reference to the signal for ,-actin, the greatest abundance of reductase mRNA was observed in the heart, liver, pancreas and kidney ( Figure 5a , lanes 1, 5, 7 and 8) with relative absorbances of 2.0, 2.0, 1.9 and 1.4 respectively. Northern hybridization with a /?-actin probe showed that there are two enzymes of fi-actin present in heart and skeletal muscle, namely a 2 kb one and a slightly smaller one of 1.6-1.8 kb (Giovanna et al., 1991; Lamballe et al., 1991) . The other tissues have one mRNA of approx. 2 kb (Figure 5b ).
When genomic DNA was digested and double-digested with EcoRI and HindlIl and the products analysed by Southern blot hybridization with the hRedT as a probe, to obtain information on the gene(s) encoding the mitochondrial 2,4-dienoyl-CoA reductase, five fragments were detected in the case of both EcoRI (7.0, 6.0, 5.1, 3.1 and 2.3 kb) and HindIll (8.8, 4.6, 3.1, 2.7 and 1.3 kb), whereas double-digestion yielded six fragments (6.0, 4.9, 4.5, 2.4, 2.2 and 2.1 kb) (Figure 6 ). This restriction fragment pattern and the restriction map constructed by the DNASIS program suggest that the size of the reductase gene is approx. 22 kb.
DISCUSSION
Chromatographic characterization of 2,4-dienoyl-CoA reductase activity in the rat liver by subcellular fractionation, together with immunological experiments, have shown that the 120 kDa isoform of reductase in the rat originates from the mitochondria (Hakkola et al., 1989; Hakkola and Hiltunen, 1993) . The conclusion that the human reductase cloned here represents the human counterpart of this same isoform is allowed by the observations of (a) a high degree of similarity between the nucleotide sequences of the rat and human 2,4-dienoyl-CoA reductase cDNAs, (b) the similar deduced amino acid sequences and hydrophobicity analysis blots (results not shown) for the rat and human reductases and (c) immunological cross-reactivity.
Sequencing of isolated undigested rat reductase has shown the N-terminal sequence of the mature enzyme to be Ser-Ile-AspAla- (Hirose et al., 1990) . Speculating on the observed size difference, one can note that the human polypeptide sequence Arg23-Phe24-Phe25-Ser26 agrees with one cleavage motif of the mitochondrial targeting peptides, Arg-X-Phe-Ser (Gavel and von Heijne, 1990) , in which the cleavage occurs at -X-Phe-. The functionality of this model is demonstrated by the maturation pattern of rat mitochondrial short-chain A3,A2-enoyl-CoA isomerase, for example (Palosaari et al., 1991) . This will result in a mature human enzyme 10 amino acids larger than that in the rat, and this estimation agrees with the results of immunoblotting of human and rat liver samples with the antibody to rat reductase, i.e. the detected signal in human sample was slightly larger than that in rat (Figure 4 ). The helical wheel of the N-terminus of human reductase shows that the basic amino asid residues Lys2, Arg6 and Arg'4 are located on the same side of the wheel, the opposite side being occupied mainly by hydrophobic amino acid residues (results not shown). Furthermore, the predicted polypeptide does not contain acidic amino acid residues, and thus the structural composition of the predicted mitochondrial targeting signal follows the general topology of N-terminal intramitochondrial targeting polypeptides (von Heijne, 1986; Roise et al., 1986) .
All the known 2,4-dienoyl-CoA reductases catalyse a NADPHdependent, but not NADH-dependent, reduction of 2,4-dienoylCoAs, and the human reductase follows this rule (E. H. Hakkola and J. K. Hiltunen, unpublished work). The nucleotide-binding sites of NADP(H)+ in nicotinamide adenine dinucleotide-dependent enzymes show a highly conserved 8lacfl2 fold, which includes a motif -H-X-H-X-Gly-X-Gly-X-X-Gly-X-X-X-H-X-X-H ... Asp/Glu-(H, hydrophobic amino acid residue) (Wierenga et al., 1983) . The sequence that comes closest to this structure in human reductase is -Ala62-X-Ile64-X-Gly66-X-Gly68-X-X-Leu71-X-X-X-Met75-X-X-Leu78 ... Asp94-, which fits the consensus motif except that the third Gly is replaced by Leu7". It has been shown, however, that the third Gly of the binding motif is not conserved at all in the NADPH-dependent enzyme (McKie and Douglas, 1991) . The 120 kDa reductase shows tissue-specific expression in the human being, its highest mRNA levels being in the myocardium, liver and pancreas, which are tissues known to be capable of oxidative degradation of fatty acids (Shipp et al., 1961; Lee et al., 1962; Weidemann and Krebs, 1969; Johnston, 1977) . Interestingly, the reductase was also expressed at low level in the placenta, and we have made the same observation regarding the other auxillary enzymes of f-oxidation, notably A3,A2-enoylCoA isomerase (H. M. Hayrinen and J. K. Hiltunen, unpublished work) .
Over 20 inborn errors of either mitochondrial or peroxisomal fl-oxidation have been identified in human beings and characterized to different extents, and these include one reported case of 2,4-dienoyl-CoA reductase deficiency. However, no inborn errors in the oxidative degradation of unsaturated fatty acids have been characterized at the molecular level so far. This work will therefore provide a tool for the screening and molecular characterization of inborn errors in unsaturated fatty acid metabolism.
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